The Dogged Search for Cryptic Effects of Ticagrelor: Wishful Thinking or Real Benefits Beyond P2Y12 Inhibition?

Circulation. 2016 Nov 29;134(22):1720-1723. doi: 10.1161/CIRCULATIONAHA.116.024710. Epub 2016 Oct 27.

¹ From Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Falls Church, VA (P.A.G., U.S.T.); and Cardiovascular Center, Changwon Gyeongsang National University Hospital, Gyeongsangnam-do, Republic of Korea (Y.-H.J.). Paul.Gurbel@inova.org.
² From Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Falls Church, VA (P.A.G., U.S.T.); and Cardiovascular Center, Changwon Gyeongsang National University Hospital, Gyeongsangnam-do, Republic of Korea (Y.-H.J.).

No abstract available

Keywords: Editorials; clopidogrel; platelet aggregation inhibitor; purinergic P2Y receptor antagonists; reperfusion injury.

Publication types